Allergan wins round in patent fight over Lumigan
WASHINGTON, Jan 28 (Reuters) - Specialty pharmaceutical company Allergan Inc won a round in a patent fight against two generic drug makers on Monday when an appeals court found a key portion of the patent for its glaucoma drug, Lumigan, was valid.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
//-->